Bactroban Nasal
 Bactroban Ointment

drug-information.ru

|Bactroban Nasal Bactroban Ointment

Drugs search, click the first letter of a drug name:


| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9  Home

Bactroban Nasal


Generic Name: mupirocin calcium
Dosage Form: Nasal ointment 2%

Bactroban Nasal Description

Bactroban Nasal (mupirocin calcium ointment, 2%) contains the dihydrate crystalline calcium hemi-salt of the antibiotic mupirocin. Chemically, it is (αE,2S,3R,4R,5S) - 5 - [(2S,3S,4S,5S) - 2,3 - Epoxy - 5 - hydroxy - 4 - methylhexyl]tetrahydro - 3,4 - dihydroxy - β - methyl - 2H - pyran - 2 - crotonic acid, ester with 9-hydroxynonanoic acid, calcium salt (2:1), dihydrate.

The molecular formula of mupirocin calcium is (C26H43O9)2Ca•2H2O, and the molecular weight is 1075.3. The molecular weight of mupirocin free acid is 500.6. The structural formula of mupirocin calcium is:

BACTROBAN NASALis a white to off-white ointment that contains 2.15% w/w mupirocin calcium (equivalent to 2.0% pure mupirocin free acid) in a soft white ointment base. The inactive ingredients are paraffin and a mixture of glycerin esters (SOFTISAN® 649).

Bactroban Nasal - Clinical Pharmacology

Pharmacokinetics

Following single or repeated intranasal applications of 0.2 gram of Bactroban Nasal 3 times daily for 3 days to 5 healthy adult male subjects, no evidence of systemic absorption of mupirocin was demonstrated. The dosage regimen used in this study was for pharmacokinetic characterization only. (See DOSAGE AND ADMINISTRATION for proper clinical dosing information.)

In this study, the concentrations of mupirocin in urine and of monic acid in urine and serum were below the limit of determination of the assay for up to 72 hours after the applications. The lowest levels of determination of the assay used were 50 ng/mL of mupirocin in urine, 75 ng/mL of monic acid in urine, and 10 ng/mL of monic acid in serum. Based on the detectable limit of the urine assay for monic acid, one can extrapolate that a mean of 3.3% (range: 1.2 to 5.1%) of the applied dose could be systemically absorbed from the nasal mucosa ofadults.

Data from a report of a pharmacokinetic study in neonates and premature infants indicate that, unlike in adults, significant systemic absorption occurred following intranasal administration of Bactroban Nasal in this population. At this time, the pharmacokinetic properties of mupirocin following intranasal application of Bactroban Nasalhave not been adequately characterized in neonates or other children less than 12 years of age, and in addition, the safety of the product in children less than 12 years of age has not been established.

The effect of the concurrent application of intranasal mupirocin calcium ointment, 2% with other intranasal products has not been studied. (See PRECAUTIONS, Drug Interactions.)

Following intravenous or oral administration, mupirocin is rapidly metabolized. The principal metabolite, monic acid, demonstrates no antibacterial activity. In a study conducted in 7 healthy adult male subjects, the elimination half-life after intravenous administration of mupirocin was 20 to 40 minutes for mupirocin and 30 to 80 minutes for monic acid. Monic acid is predominantly eliminated by renal excretion. The pharmacokinetics of mupirocin has not been studied in individuals with renal insufficiency.

Microbiology

Mupirocin is an antibacterial agent produced by fermentation using the organism Pseudomonas fluorescens. Mupirocin inhibits bacterial protein synthesis by reversibly and specifically binding to bacterial isoleucyl transfer-RNA synthetase. Due to this mode of action, mupirocin demonstrates no in vitro cross-resistance with other classes of antimicrobial agents.

When mupirocin resistance does occur, it appears to result from the production of a modified isoleucyl-tRNA synthetase. High-level plasmid-mediated resistance (MIC >1,024 mcg/mL) has been reported in some strains of Staphylococcus aureus and coagulase-negative staphylococci.

Mupirocin is bactericidal at concentrations achieved topically by intranasal administration. However, the minimum bactericidal concentration (MBC) against relevant intranasal pathogens is generally 8-fold to 30-fold higher than the minimum inhibitory concentration (MIC). In addition, mupirocin is highly protein bound (>97%), and the effect of nasal secretions on the MICs of intranasally applied mupirocin has not been determined.

Mupirocin has been shown to be active against most strains of methicillin-resistant S. aureus, both in vitro and in clinical studies of the eradication of nasal colonization. Bactroban Nasalonly has established clinical utility in nasal eradication as part of a comprehensive program to curtail institutional outbreaks of infections with methicillin-resistant S. aureus. (See INDICATIONS AND USAGE.)

The following in vitro data are available, but their clinical significance is unknown. Mupirocin exhibits in vitro MICs of 1 mcg/mL or less against most (>90%) strains of methicillin-susceptible S. aureus; however, the safety and effectiveness of mupirocin calcium in eradicating nasal colonization of and preventing subsequent infections due to methicillin-susceptible S. aureus have not been established.

Indications and Usage for Bactroban Nasal

Bactroban Nasal is indicated for the eradication of nasal colonization with methicillin-resistant S. aureus in adult patients and health care workers as part of a comprehensive infection control program to reduce the risk of infection among patients at high risk of methicillin-resistant S. aureus infection during institutional outbreaks of infections with this pathogen.

NOTE:

  1. There are insufficient data at this time to establish that this product is safe and effective as part of an intervention program to prevent autoinfection of high-risk patients from their own nasal colonization with S. aureus.
  2. There are insufficient data at this time to recommend use of BACTROBAN NASALfor general prophylaxis of any infection in any patient population.
  3. Greater than 90% of subjects/patients in clinical trials had eradication of nasal colonization 2 to 4 days after therapy was completed. Approximately 30% recolonization was reported in 1 domestic study within 4 weeks after completion of therapy. These eradication rates were clinically and statistically superior to those reported in subjects/patients in the vehicle-treated arms of the adequate and well-controlled studies. Those treated with vehicle had eradication rates of 5% to 30% at 2 to 4 days post-therapy with 85% to 100% recolonization within 4 weeks.

All adequate and well-controlled trials of this product were vehicle-controlled; therefore, no data from direct, head-to-head comparisons with other products are available at this time.

Contraindications

Bactroban Nasalis contraindicated in patients with known hypersensitivity to any of the constituents of the product.

Warnings

AVOID CONTACT WITH THE EYES. Application of Bactroban Nasal to the eye under testing conditions has caused severe symptoms such as burning and tearing. These symptoms resolved within days to weeks after discontinuation of the ointment.

In the event of a sensitization or severe local irritation from Bactroban Nasal, usage should be discontinued.

Precautions

General

As with other antibacterial products, prolonged use may result in overgrowth of nonsusceptible microorganisms, including fungi. (See DOSAGE AND ADMINISTRATION.)

Information for Patients

Patients should be given the following instructions:

− Apply approximately one-half of the ointment from the single-use tube directly into 1 nostril and the other half into the other nostril;

− Avoid contact of the medication with the eyes;

− Discard the tube after using, do not re-use;

− Press the sides of the nose together and gently massage after application to spread the ointment throughout the inside of the nostrils; and

− Discontinue usage of the medication and call your health care practitioner if sensitization or severe local irritation occurs.

Drug Interactions

The effect of the concurrent application of intranasal mupirocin calcium and other intranasal products has not been studied. Until further information is known, mupirocin calcium ointment, 2% should not be applied concurrently with any other intranasal products.

Carcinogenesis, Mutagenesis, Impairment of Fertility

Long-term studies in animals to evaluate carcinogenic potential of mupirocin calcium have not been conducted.

Results of the following studies performed with mupirocin calcium or mupirocin sodium in vitro and in vivo did not indicate a potential for mutagenicity: Rat primary hepatocyte unscheduled DNA synthesis, sediment analysis for DNA strand breaks, Salmonella reversion test (Ames), Escherichia coli mutation assay, metaphase analysis of human lymphocytes, mouse lymphoma assay, and bone marrow micronuclei assay in mice.

Reproduction studies were performed in rats with mupirocin administered subcutaneously at doses up to 40 times the human intranasal dose (approximately 20 mg mupirocin per day) on a mg/m2 basis and revealed no evidence of impaired fertility from mupirocin sodium.

Pregnancy

Teratogenic Effects.

Pregnancy Category B

Reproduction studies have been performed in rats and rabbits with mupirocin administered subcutaneously at doses up to 65 and 130 times, respectively, the human intranasal dose (approximately 20 mg mupirocin per day) on a mg/m2 basis and revealed no evidence of harm to the fetus due to mupirocin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Nursing Mothers

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Bactroban Nasalis administered to a nursing woman.

Pediatric Use

Safety in children under the age of 12 years has not been established. (See CLINICAL PHARMACOLOGY.)

Adverse Reactions

Clinical Trials

In clinical trials, 210 domestic and 2,130 foreign adult subjects/patients received Bactroban Nasalointment. Less than 1% of domestic or foreign subjects and patients in clinical trials were withdrawn due to adverse events.

The most frequently reported adverse events in foreign clinical trials were as follows: rhinitis (1.0%), taste perversion (0.8%), pharyngitis (0.5%).

In domestic clinical trials, 17% (36/210) of adults treated with Bactroban Nasalointment reported adverse events thought to be at least possibly drug-related. The incidence of adverse events that were reported in at least 1% of adults enrolled in domestic clinical trials were as follows:

ADVERSE EVENTS (≥1% INCIDENCE)-ADULTS IN US TRIALS

% of Subjects/Patients Experiencing Event

BACTROBAN NASAL

(n=210)

Headache

9%

Rhinitis

6%

Respiratory disorder, including

upper respiratory tract congestion

5%

Pharyngitis

4%

Taste perversion

3%

Burning/stinging

2%

Cough

2%

Pruritus

1%

The following events thought possibly drug-related were reported in less than 1% of adults enrolled in domestic clinical trials: Blepharitis, diarrhea, dry mouth, ear pain, epistaxis, nausea, and rash.

All adequate and well-controlled clinical trials have been performed using BACTROBAN NASALointment, 2% in 1 arm and the vehicle ointment in the other arm of the study. No adequate and well-controlled safety data are available from direct, head-to-head comparative studies of this product and other products for this indication.

Overdosage

Following single or repeated intranasal applications of Bactroban Nasalto adults, no evidence for systemic absorption of mupirocin was obtained. Intravenous infusions of 252 mg, as well as single oral doses of 500 mg of mupirocin, have been well tolerated in healthy adult subjects. There is no information regarding local overdose of Bactroban Nasalor regarding oral ingestion of the nasal ointment formulation.

Bactroban Nasal Dosage and Administration

(See INDICATIONS AND USAGE.)

Adults (12 years of age and older)

Approximately one-half of the ointment from the single-use tube should be applied into 1 nostril and the other half into the other nostril twice daily (morning and evening) for 5 days.

After application, the nostrils should be closed by pressing together and releasing the sides of the nose repetitively for approximately 1 minute. This will spread the ointment throughout the nares.

The single-use 1.0 gram tube will deliver a total of approximately 0.5 grams of the ointment (approximately 0.25 grams/nostril).

The tube should be discarded after usage; it should not be re-used.

The safety and effectiveness of applications of this medication for greater than 5 days have not been established. There are no human clinical or pre-clinical animal data to support the use of this product in a chronic manner or in manners other than those described in this package insert.

Until further information is known, Bactroban Nasalshould not be applied concurrently with any other intranasal products.

How is Bactroban Nasal Supplied

Bactroban Nasal is supplied in 1.0-gram tubes packaged in cartons of 10.

NDC 0029-1526-11 (1.0 gram tubes in packages of 10).

Store at or below 25°C (77°F).

REFERENCE

  1. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically—Third Edition; Approved Standard NCCLS Document M7-A3. Vol. 12, No. 25, NCCLS, Villanova, PA, December 1993.

Bactroban Nasal is a registered trademark of GlaxoSmithKline.

SOFTISAN is a registered trademark of Sasol Olefins & Surfactants GmbH.

Manufactured by DPT Laboratories

San Antonio, TX 78215

Distributed by

GlaxoSmithKline

Research Triangle Park, NC 27709

©2004, GlaxoSmithKline. All rights reserved.

July 2004 BN:L5B


BACTROBAN (mupirocin calcium)
PRODUCT INFO
Product Code 0029-1526 Dosage Form OINTMENT
Route Of Administration NASAL DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
mupirocin calcium (mupirocin) Active 20 MILLIGRAM  In 1 GRAM
paraffin Inactive  
Softisan 649 Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 0029-1526-11 10 TUBE In 1 CARTON contains a TUBE
1 1 GRAM In 1 TUBE This package is contained within the CARTON (0029-1526-11)

Revised: 01/2006





Where can I get more information about Bactroban Nasal Bactroban Ointment ? We recommend to use www.Drugs.com

Typical mistypes for Bactroban Nasal Bactroban Ointment
vactroban nasal bactroban ointment, nactroban nasal bactroban ointment, hactroban nasal bactroban ointment, gactroban nasal bactroban ointment, bzctroban nasal bactroban ointment, bsctroban nasal bactroban ointment, bwctroban nasal bactroban ointment, bqctroban nasal bactroban ointment, baxtroban nasal bactroban ointment, bavtroban nasal bactroban ointment, baftroban nasal bactroban ointment, badtroban nasal bactroban ointment, bacrroban nasal bactroban ointment, bacfroban nasal bactroban ointment, bacgroban nasal bactroban ointment, bacyroban nasal bactroban ointment, bac6roban nasal bactroban ointment, bac5roban nasal bactroban ointment, bacteoban nasal bactroban ointment, bactdoban nasal bactroban ointment, bactfoban nasal bactroban ointment, bacttoban nasal bactroban ointment, bact5oban nasal bactroban ointment, bact4oban nasal bactroban ointment, bactriban nasal bactroban ointment, bactrkban nasal bactroban ointment, bactrlban nasal bactroban ointment, bactrpban nasal bactroban ointment, bactr0ban nasal bactroban ointment, bactr9ban nasal bactroban ointment, bactrovan nasal bactroban ointment, bactronan nasal bactroban ointment, bactrohan nasal bactroban ointment, bactrogan nasal bactroban ointment, bactrobzn nasal bactroban ointment, bactrobsn nasal bactroban ointment, bactrobwn nasal bactroban ointment, bactrobqn nasal bactroban ointment, bactrobab nasal bactroban ointment, bactrobam nasal bactroban ointment, bactrobaj nasal bactroban ointment, bactrobah nasal bactroban ointment, bactroban basal bactroban ointment, bactroban masal bactroban ointment, bactroban jasal bactroban ointment, bactroban hasal bactroban ointment, bactroban nzsal bactroban ointment, bactroban nssal bactroban ointment, bactroban nwsal bactroban ointment, bactroban nqsal bactroban ointment, bactroban naaal bactroban ointment, bactroban nazal bactroban ointment, bactroban naxal bactroban ointment, bactroban nadal bactroban ointment, bactroban naeal bactroban ointment, bactroban nawal bactroban ointment, bactroban naszl bactroban ointment, bactroban nassl bactroban ointment, bactroban naswl bactroban ointment, bactroban nasql bactroban ointment, bactroban nasak bactroban ointment, bactroban nasap bactroban ointment, bactroban nasao bactroban ointment, bactroban nasal vactroban ointment, bactroban nasal nactroban ointment, bactroban nasal hactroban ointment, bactroban nasal gactroban ointment, bactroban nasal bzctroban ointment, bactroban nasal bsctroban ointment, bactroban nasal bwctroban ointment, bactroban nasal bqctroban ointment, bactroban nasal baxtroban ointment, bactroban nasal bavtroban ointment, bactroban nasal baftroban ointment, bactroban nasal badtroban ointment, bactroban nasal bacrroban ointment, bactroban nasal bacfroban ointment, bactroban nasal bacgroban ointment, bactroban nasal bacyroban ointment, bactroban nasal bac6roban ointment, bactroban nasal bac5roban ointment, bactroban nasal bacteoban ointment, bactroban nasal bactdoban ointment, bactroban nasal bactfoban ointment, bactroban nasal bacttoban ointment, bactroban nasal bact5oban ointment, bactroban nasal bact4oban ointment, bactroban nasal bactriban ointment, bactroban nasal bactrkban ointment, bactroban nasal bactrlban ointment, bactroban nasal bactrpban ointment, bactroban nasal bactr0ban ointment, bactroban nasal bactr9ban ointment, bactroban nasal bactrovan ointment, bactroban nasal bactronan ointment, bactroban nasal bactrohan ointment, bactroban nasal bactrogan ointment, bactroban nasal bactrobzn ointment, bactroban nasal bactrobsn ointment, bactroban nasal bactrobwn ointment, bactroban nasal bactrobqn ointment, bactroban nasal bactrobab ointment, bactroban nasal bactrobam ointment, bactroban nasal bactrobaj ointment, bactroban nasal bactrobah ointment, bactroban nasal bactroban iintment, bactroban nasal bactroban kintment, bactroban nasal bactroban lintment, bactroban nasal bactroban pintment, bactroban nasal bactroban 0intment, bactroban nasal bactroban 9intment, bactroban nasal bactroban ountment, bactroban nasal bactroban ojntment, bactroban nasal bactroban okntment, bactroban nasal bactroban oontment, bactroban nasal bactroban o9ntment, bactroban nasal bactroban o8ntment, bactroban nasal bactroban oibtment, bactroban nasal bactroban oimtment, bactroban nasal bactroban oijtment, bactroban nasal bactroban oihtment, bactroban nasal bactroban oinrment, bactroban nasal bactroban oinfment, bactroban nasal bactroban oingment, bactroban nasal bactroban oinyment, bactroban nasal bactroban oin6ment, bactroban nasal bactroban oin5ment, bactroban nasal bactroban ointnent, bactroban nasal bactroban ointkent, bactroban nasal bactroban ointjent, bactroban nasal bactroban ointmwnt, bactroban nasal bactroban ointmsnt, bactroban nasal bactroban ointmdnt, bactroban nasal bactroban ointmrnt, bactroban nasal bactroban ointm4nt, bactroban nasal bactroban ointm3nt, bactroban nasal bactroban ointmebt, bactroban nasal bactroban ointmemt, bactroban nasal bactroban ointmejt, bactroban nasal bactroban ointmeht, bactroban nasal bactroban ointmenr, bactroban nasal bactroban ointmenf, bactroban nasal bactroban ointmeng, bactroban nasal bactroban ointmeny, bactroban nasal bactroban ointmen6, bactroban nasal bactroban ointmen5, actroban nasal bactroban ointment, bctroban nasal bactroban ointment, batroban nasal bactroban ointment, bacroban nasal bactroban ointment, bactoban nasal bactroban ointment, bactrban nasal bactroban ointment, bactroan nasal bactroban ointment, bactrobn nasal bactroban ointment, bactroba nasal bactroban ointment, bactrobannasal bactroban ointment, bactroban asal bactroban ointment, bactroban nsal bactroban ointment, bactroban naal bactroban ointment, bactroban nasl bactroban ointment, bactroban nasa bactroban ointment, bactroban nasal bactroban ointment, bactroban nasal bactroban ointment, bactroban nasal actroban ointment, bactroban nasal bctroban ointment, bactroban nasal batroban ointment, bactroban nasal bacroban ointment, bactroban nasal bactoban ointment, bactroban nasal bactrban ointment, bactroban nasal bactroan ointment, bactroban nasal bactrobn ointment, bactroban nasal bactroba ointment, bactroban nasal bactrobanointment, bactroban nasal bactroban intment, bactroban nasal bactroban ontment, bactroban nasal bactroban oitment, bactroban nasal bactroban oinment, bactroban nasal bactroban ointent, bactroban nasal bactroban ointmnt, bactroban nasal bactroban ointmet, bactroban nasal bactroban ointmen, abctroban nasal bactroban ointment, bcatroban nasal bactroban ointment, batcroban nasal bactroban ointment, bacrtoban nasal bactroban ointment, bactorban nasal bactroban ointment, bactrboan nasal bactroban ointment, bactroabn nasal bactroban ointment, bactrobna nasal bactroban ointment, bactroba nnasal bactroban ointment, bactrobann asal bactroban ointment, bactroban ansal bactroban ointment, bactroban nsaal bactroban ointment, bactroban naasl bactroban ointment, bactroban nasla bactroban ointment, bactroban nasa l bactroban ointment, bactroban nasal bactroban ointment, bactroban nasal b actroban ointment, bactroban nasal abctroban ointment, bactroban nasal bcatroban ointment, bactroban nasal batcroban ointment, bactroban nasal bacrtoban ointment, bactroban nasal bactorban ointment, bactroban nasal bactrboan ointment, bactroban nasal bactroabn ointment, bactroban nasal bactrobna ointment, bactroban nasal bactroba nointment, bactroban nasal bactrobano intment, bactroban nasal bactroban iontment, bactroban nasal bactroban onitment, bactroban nasal bactroban oitnment, bactroban nasal bactroban oinmtent, bactroban nasal bactroban ointemnt, bactroban nasal bactroban ointmnet, bactroban nasal bactroban ointmetn, bbactroban nasal bactroban ointment, baactroban nasal bactroban ointment, bacctroban nasal bactroban ointment, bacttroban nasal bactroban ointment, bactrroban nasal bactroban ointment, bactrooban nasal bactroban ointment, bactrobban nasal bactroban ointment, bactrobaan nasal bactroban ointment, bactrobann nasal bactroban ointment, bactroban nasal bactroban ointment, bactroban nnasal bactroban ointment, bactroban naasal bactroban ointment, bactroban nassal bactroban ointment, bactroban nasaal bactroban ointment, bactroban nasall bactroban ointment, bactroban nasal bactroban ointment, bactroban nasal bactroban ointment, bactroban nasal bbactroban ointment, bactroban nasal baactroban ointment, bactroban nasal bacctroban ointment, bactroban nasal bacttroban ointment, bactroban nasal bactrroban ointment, bactroban nasal bactrooban ointment, bactroban nasal bactrobban ointment, bactroban nasal bactrobaan ointment, bactroban nasal bactrobann ointment, bactroban nasal bactroban ointment, bactroban nasal bactroban oointment, bactroban nasal bactroban oiintment, bactroban nasal bactroban oinntment, bactroban nasal bactroban ointtment, bactroban nasal bactroban ointmment, bactroban nasal bactroban ointmeent, bactroban nasal bactroban ointmennt, bactroban nasal bactroban ointmentt, etc.


© Copyright by drug-information.ru 2001-2012. All rights reserved